Maxygen, Inc. Plans Staff Cuts After Forming R&D Joint Venture With Astellas Pharma Inc.

BizJournals -- Maxygen Inc. and Japanese drug maker Astellas Pharma Inc. will start an R&D joint venture focused on protein drugs but largely spelling the beginning of the end of the Redwood City company as it is known today.